GREGORY A. KELLY P.E. NAMED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF STV

NEW YORK, Oct. 13, 2020 /PRNewswire/ -- STV Group's Board of Directors has named Gregory A. Kelly, P.E., president and chief executive officer, effective October 26, 2020. In this role, Kelly will be responsible for guiding the firm toward achieving its short- and long-term strategic goals with an emphasis on performance, business development, t [...]

CABLE ONE COMPLETES CONTRIBUTION OF ALABAMA ASSETS TO HARGRAY

HILTON HEAD, SC AND PHOENIX — October 1, 2020 — Hargray Communications (“Hargray”) and Cable One, Inc. (NYSE: CABO) (“Cable One”) announced today that the companies have completed the contribution of Cable One’s system serving Anniston, Alabama and surrounding areas, which operatesunder the Sparklight® brand, to Hargray in exchang [...]

SYSTEMS ONCOLOGY, AN AI-BASED CANCER THERAPY DISCOVERY AND DEVELOPMENT COMPANY, IS HONORED WITH A 2020 AZBIO FAST LANE AWARD

CHANDLER, Ariz.--(BUSINESS WIRE)--The Arizona Bioindustry Association (AZBio) today announced that Systems Oncology, LLC, an AI-based cancer therapy discovery and development company, was honored during Arizona Bioscience Week with a 2020 AZBio Fast Lane Award. Systems Oncology’s work was featured in Celebrating Life & Science, a one-hour tele [...]

DATAMINR NAMED TO THE 2020 FORBES CLOUD 100 RANKING

NEW YORK, Sept. 16, 2020 /PRNewswire/ -- For the fourth consecutive year, Dataminr has been named to the Forbes 2020 Cloud 100, the definitive ranking of the top 100 private cloud companies in the world, published by Forbes in partnership with Bessemer Venture Partners and Salesforce Ventures.As part of the rigorous selection process for the For [...]

SIGNIFIER MEDICAL TECHNOLOGIES CLOSES $10M SERIES C FUNDING ROUND

BOSTON and LONDON, Sept. 16, 2020 /PRNewswire/ -- Signifier Medical Technologies ("Signifier"), an innovator in the sleep disordered breathing market, today announced it has closed a circa $10M Series C funding round led by Alan Howard, VC investor and co-founder of Brevan Howard. The proceeds from this latest successful fundraising will allow S [...]

BAYER AND SYSTEMS ONCOLOGY SIGN EXCLUSIVE LICENSE AGREEMENT FOR INVESTIGATIONAL BREAST CANCER TREATMENT APPROACH ERSOTM

WHIPPANY, N.J., September 15, 2020 – Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO, a compound in pre-clinical development for metastatic Estrogen Receptor (ER) positive, breast cancer. ERSO is a small molecule activator of the Unfolded Protein Response (UPR) in ER-positive breast cancer cell [...]

BAYER AND SYSTEMS ONCOLOGY SIGN EXCLUSIVE LICENSE AGREEMENT FOR INVESTIGATIONAL BREAST CANCER TREATMENT APPROACH ERSO™

WHIPPANY, N.J., September 15, 2020 – Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for metastatic Estrogen Receptor (ER) positive, breast cancer. ERSO is a small molecule activator of the Unfolded Protein Response (UPR) in ER-positive breast canc [...]

1 10 11 12 13 14 17